249 related articles for article (PubMed ID: 26791788)
1. Lungtech, a phase II EORTC trial of SBRT for centrally located lung tumours - a clinical physics perspective.
Lambrecht M; Melidis C; Sonke JJ; Adebahr S; Boellaard R; Verheij M; Guckenberger M; Nestle U; Hurkmans C
Radiat Oncol; 2016 Jan; 11():7. PubMed ID: 26791788
[TBL] [Abstract][Full Text] [Related]
2. Results of a multicentre dosimetry audit using a respiratory phantom within the EORTC LungTech trial.
Lambrecht ML; Eaton DJ; Sonke JJ; Nestle U; Peulen H; Weber DC; Verheij M; Hurkmans CW
Radiother Oncol; 2019 Sep; 138():106-113. PubMed ID: 31252291
[TBL] [Abstract][Full Text] [Related]
3. Radiotherapy quality assurance of SBRT for patients with centrally located lung tumours within the multicentre phase II EORTC Lungtech trial: Benchmark case results.
Lambrecht M; Clementel E; Sonke JJ; Nestle U; Adebahr S; Guckenberger M; Andratschke N; Weber DC; Verheij M; Hurkmans CW
Radiother Oncol; 2019 Mar; 132():63-69. PubMed ID: 30825971
[TBL] [Abstract][Full Text] [Related]
4. Dosimetric comparison of stereotactic body radiotherapy using 4D CT and multiphase CT images for treatment planning of lung cancer: evaluation of the impact on daily dose coverage.
Wang L; Hayes S; Paskalev K; Jin L; Buyyounouski MK; Ma CC; Feigenberg S
Radiother Oncol; 2009 Jun; 91(3):314-24. PubMed ID: 19111362
[TBL] [Abstract][Full Text] [Related]
5. The relative accuracy of 4D dose accumulation for lung radiotherapy using rigid dose projection versus dose recalculation on every breathing phase.
Valdes G; Lee C; Tenn S; Lee P; Robinson C; Iwamoto K; Low D; Lamb JM
Med Phys; 2017 Mar; 44(3):1120-1127. PubMed ID: 28019649
[TBL] [Abstract][Full Text] [Related]
6. Dosimetric verification in participating institutions in a stereotactic body radiotherapy trial for stage I non-small cell lung cancer: Japan clinical oncology group trial (JCOG0403).
Nishio T; Kunieda E; Shirato H; Ishikura S; Onishi H; Tateoka K; Hiraoka M; Narita Y; Ikeda M; Goka T
Phys Med Biol; 2006 Nov; 51(21):5409-17. PubMed ID: 17047260
[TBL] [Abstract][Full Text] [Related]
7. Planning benchmark study for SBRT of early stage NSCLC : Results of the DEGRO Working Group Stereotactic Radiotherapy.
Moustakis C; Blanck O; Ebrahimi Tazehmahalleh F; Ka Heng Chan M; Ernst I; Krieger T; Duma MN; Oechsner M; Ganswindt U; Heinz C; Alheit H; Blank H; Nestle U; Wiehle R; Kornhuber C; Ostheimer C; Petersen C; Pollul G; Baus W; Altenstein G; Beckers E; Jurianz K; Sterzing F; Kretschmer M; Seegenschmiedt H; Maass T; Droege S; Wolf U; Schoeffler J; Haverkamp U; Eich HT; Guckenberger M
Strahlenther Onkol; 2017 Oct; 193(10):780-790. PubMed ID: 28567503
[TBL] [Abstract][Full Text] [Related]
8. Dosimetric impact of breathing motion in lung stereotactic body radiotherapy treatment using intensity modulated radiotherapy and volumetric modulated arc therapy [corrected].
Rao M; Wu J; Cao D; Wong T; Mehta V; Shepard D; Ye J
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):e251-6. PubMed ID: 22365622
[TBL] [Abstract][Full Text] [Related]
9. 4D VMAT, gated VMAT, and 3D VMAT for stereotactic body radiation therapy in lung.
Chin E; Loewen SK; Nichol A; Otto K
Phys Med Biol; 2013 Feb; 58(4):749-70. PubMed ID: 23324560
[TBL] [Abstract][Full Text] [Related]
10. Quality assurance of 4D-CT scan techniques in multicenter phase III trial of surgery versus stereotactic radiotherapy (radiosurgery or surgery for operable early stage (stage 1A) non-small-cell lung cancer [ROSEL] study).
Hurkmans CW; van Lieshout M; Schuring D; van Heumen MJ; Cuijpers JP; Lagerwaard FJ; Widder J; van der Heide UA; Senan S
Int J Radiat Oncol Biol Phys; 2011 Jul; 80(3):918-27. PubMed ID: 20950961
[TBL] [Abstract][Full Text] [Related]
11. Global harmonization of quality assurance naming conventions in radiation therapy clinical trials.
Melidis C; Bosch WR; Izewska J; Fidarova E; Zubizarreta E; Ulin K; Ishikura S; Followill D; Galvin J; Haworth A; Besuijen D; Clark CH; Miles E; Aird E; Weber DC; Hurkmans CW; Verellen D
Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1242-9. PubMed ID: 25539374
[TBL] [Abstract][Full Text] [Related]
12. LungTech, an EORTC Phase II trial of stereotactic body radiotherapy for centrally located lung tumours: a clinical perspective.
Adebahr S; Collette S; Shash E; Lambrecht M; Le Pechoux C; Faivre-Finn C; De Ruysscher D; Peulen H; Belderbos J; Dziadziuszko R; Fink C; Guckenberger M; Hurkmans C; Nestle U
Br J Radiol; 2015 Jul; 88(1051):20150036. PubMed ID: 25873481
[TBL] [Abstract][Full Text] [Related]
13. Synthetic 4D-CT of the thorax for treatment plan adaptation on MR-guided radiotherapy systems.
Freedman JN; Bainbridge HE; Nill S; Collins DJ; Kachelrieß M; Leach MO; McDonald F; Oelfke U; Wetscherek A
Phys Med Biol; 2019 May; 64(11):115005. PubMed ID: 30844775
[TBL] [Abstract][Full Text] [Related]
14. Dosimetric Consequences of 3D Versus 4D PET/CT for Target Delineation of Lung Stereotactic Radiotherapy.
Siva S; Chesson B; Callahan JW; Hardcastle N; Crawford L; Antippa P; Wright G; MacManus MP; Hicks RJ; Kron T; Ball DL
J Thorac Oncol; 2015 Jul; 10(7):1112-5. PubMed ID: 26134229
[TBL] [Abstract][Full Text] [Related]
15. Verification of planning target volume settings in volumetric modulated arc therapy for stereotactic body radiation therapy by using in-treatment 4-dimensional cone beam computed tomography.
Takahashi W; Yamashita H; Kida S; Masutani Y; Sakumi A; Ohtomo K; Nakagawa K; Haga A
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(3):426-31. PubMed ID: 23562767
[TBL] [Abstract][Full Text] [Related]
16. Additional PET/CT in week 5-6 of radiotherapy for patients with stage III non-small cell lung cancer as a means of dose escalation planning?
Gillham C; Zips D; Pönisch F; Evers C; Enghardt W; Abolmaali N; Zöphel K; Appold S; Hölscher T; Steinbach J; Kotzerke J; Herrmann T; Baumann M
Radiother Oncol; 2008 Sep; 88(3):335-41. PubMed ID: 18514339
[TBL] [Abstract][Full Text] [Related]
17. Investigation of respiration induced intra- and inter-fractional tumour motion using a standard Cone Beam CT.
Gottlieb KL; Hansen CR; Hansen O; Westberg J; Brink C
Acta Oncol; 2010 Oct; 49(7):1192-8. PubMed ID: 20831512
[TBL] [Abstract][Full Text] [Related]
18. Dose calculations accounting for breathing motion in stereotactic lung radiotherapy based on 4D-CT and the internal target volume.
Admiraal MA; Schuring D; Hurkmans CW
Radiother Oncol; 2008 Jan; 86(1):55-60. PubMed ID: 18082905
[TBL] [Abstract][Full Text] [Related]
19. The feasibility of evaluating radiation dose to the heart by integrating kilovoltage-cone beam computed tomography in stereotactic body radiotherapy of early non-small-cell lung cancer patients.
Liu C; Gong G; Guo C; Liu T; Lu J; Zhao H; Dong W; Yin Y
Radiat Oncol; 2013 Dec; 8():295. PubMed ID: 24369788
[TBL] [Abstract][Full Text] [Related]
20. 3D dose delivery verification using repeated cone-beam imaging and EPID dosimetry for stereotactic body radiotherapy of non-small cell lung cancer.
van Elmpt W; Petit S; De Ruysscher D; Lambin P; Dekker A
Radiother Oncol; 2010 Feb; 94(2):188-94. PubMed ID: 20083317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
